Tag Archives: Induced Pluripotent Stem Cells

Adult stem cells therapy can fix a broken heart?

Mary sent me this article from the Irish Times.

Excerpt:

A new US study in which patients had their hearts repaired with stem cells has brought regenerative treatments for heart attacks a step closer.

The therapy, reported today in the Lancet  medical journal, halved the extent of normally permanent scarring on the heart, and led to the growth of new heart muscle.

However, the treatment produced no significant change in “ejection fraction” – a measure of the heart’s pumping capacity.

The Caduceus trial recruited a total of 25 patients with an average age of 53 who had all suffered a heart attack in the previous month.

Some 17 patients received coronary artery infusions of 12 to 25 million stem cells derived from healthy tissue taken from their own hearts. The remaining eight underwent standard post-heart attack care.

A year later, the proportion of the heart left scarred in the stem cell-treated patients had been reduced from 24 per cent to 12 per cent. No change was seen in patients who did not receive the treatment.

Professor Eduardo Marban, director of the Cedars-Sinai Heart Institute in Los Angeles, who led the US team, said: “The effects are substantial, and surprisingly larger in humans than they were in animal tests.

“This discovery challenges the conventional wisdom that, once established, scar is permanent and that, once lost, healthy heart muscle cannot be restored.”

The Phase I study, which was chiefly conducted to evaluate safety, was published today in an online edition of the Lancet.  It follows a similar trial by US scientists at Harvard Medical School and the University of Louisville whose findings were reported last year, also in the Lancet.

That study, which used a different kind of heart stem cell, produced a 12 per cent average increase in ejection fraction.

Yet another breakthrough for ethical adult stem cells.

Related posts

New study: adult stem cells are almost identical to embryonic stem cells

From Life News.

Excerpt:

Scientists at the University of Wisconsin-Madison have used detailed, high-tech analysis to examine the differences between human embryonic stem cells (ESC) and induced pluripotent stem cells (iPSC).

Their findings, published online in the journal Nature Methods, for the first time measured the differences between ESC and iPSC in terms of their proteins (the workhorses of the cell that provide structure, function, and identity for a cell), phosphorylation of proteins (a common type of protein modification used to control protein activity), and RNA (an intermediate messenger from DNA that codes for specific proteins.)  The results indicate that there is significant similarity between ESC and iPSC, with less than 1 percent difference.

ESC research relies on the destruction of a young human embryo, while iPS cells are produced by adding a few genes to normal cells, such as skin, thereby reprogramming the cell to look and act like an ESC, yet without the use of embryos, eggs, or cloning techniques.  The iPS cells thus have a couple of advantages over ESC, including their ethical production as well as the ability to produce pluripotent stem cells directly from any person, to study disease or for potential transplant matching (though the latter has not been proven.)  The similarities indicate, however, that iPSC are more than adequate alternatives to ESC.

The study points out that some differences do still exist between ESC and iPSC, likely as a result of the different origins of the two stem cell types, and that further studies will examine those differences.  But the authors state in their paper that “These differences do not appear to appreciably alter cellular function in the pluripotent state,” as in not affecting the growth and function of iPSC as a stem cell, and the “remarkable similarity between ESCs and iPSCs.”

It’s time to stop the destruction of embryos for experiments, and focus on ethical science.

See below for some adult stem cell successes.

Related posts